Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587808 · ClinicalTrials.gov registry record
Mechanisms in Heart Failure With Normal EF
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 14
- Enrollment target
NCT00587808: Completed study, sponsored by Mayo Clinic.
NCT00587808 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587808 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The guiding hypotheses are that (1) mechanisms in addition to diastolic dysfunction, while normal at rest, are compromised with stress, leading to symptoms of HF, and (2) that an increased proportion of the increase in LV diastolic pressures seen in HFpEF is mediated via exaggerated pericardial/right heart-LV coupling (restraint).
Interventions
- PROCEDURE RHC with VO2 consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-12 |
What the finished NCT00587808 record still lists
NCT00587808 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which RHC with VO2 consumption is the first listed.
NCT00587808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00587808 about?
NCT00587808 is a clinical study titled "Mechanisms in Heart Failure With Normal EF". The guiding hypotheses are that (1) mechanisms in addition to diastolic dysfunction, while normal at rest, are compromised with stress, leading to symptoms of HF, and (2) that an increased proportion of the increase in LV diastolic pressures seen in HFpEF is mediated via exaggerated pericardial/righ...
What is the current status of trial NCT00587808?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2007-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00587808?
The interventions under investigation include: RHC with VO2 consumption (PROCEDURE).
Who is sponsoring clinical trial NCT00587808?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia